Table 1.

Demographics, comorbidities, severity on admission, clinical course, microbiological isolations, and outcome.

	Patient 1	Patient 2	Patient 3
Age	51	43	24
Gender	Male	Female	Male
BMI	27	32	24
Immunosuppression	No	No	No
Comorbidities	Gout	Hypothyroidism, depression, chronic headache	None
SOFA score on admission	6	4	6
CURB-65 score on admission	0	1	2
Hospital day when MV was started	3rd	2nd	2nd
Hospital day when ECMO was started	7th	2nd	4th
Length of ECMO (days)	20	26	15
Hospital day when influenza virus assay was performed and oseltamivir started	3rd	2nd	1st
Length of oseltamivir therapy (days)	13	9	30
Nosocomial pathogens isolated	C. parapsilosis on throat specimen and S. epidermidis on BAS	P. aeruginosa MDR, C. albicans, C. glabrata, and C. parapsilosis on BAS	P. aeruginosa MDR, Flavobacterium, and C. indologenes on BAS
LP and SP urinary antigens	Negative	Negative	Negative
CP, MP, and LP IgM and IgG	Negative	Negative	Negative
Outcome	Alive	Alive	Alive

MV: mechanical ventilation; ECMO: extracorporeal membrane oxygenation; LP: L. pneumophila; SP: S. pneumoniae; CP: C. pneumoniae; MP: M. pneumoniae; BAS: bronchial aspirate; MDR: multidrug resistant (used for pathogens resistant to at least three drugs from different antibiotic categories).